SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-008159
Filing Date
2024-05-14
Accepted
2024-05-14 17:12:45
Documents
61
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cycc-20240331x10q.htm   iXBRL 10-Q 1041059
2 EX-31.1 cycc-20240331xex31d1.htm EX-31.1 14603
3 EX-31.2 cycc-20240331xex31d2.htm EX-31.2 15135
4 EX-32.1 cycc-20240331xex32d1.htm EX-32.1 5066
5 EX-32.2 cycc-20240331xex32d2.htm EX-32.2 5135
6 GRAPHIC cycc-20240331x10q001.jpg GRAPHIC 19616
7 GRAPHIC cycc-20240331x10q002.jpg GRAPHIC 33260
  Complete submission text file 0001558370-24-008159.txt   5138247

Data Files

Seq Description Document Type Size
8 EX-101.SCH cycc-20240331.xsd EX-101.SCH 41733
9 EX-101.CAL cycc-20240331_cal.xml EX-101.CAL 34924
10 EX-101.DEF cycc-20240331_def.xml EX-101.DEF 206972
11 EX-101.LAB cycc-20240331_lab.xml EX-101.LAB 339019
12 EX-101.PRE cycc-20240331_pre.xml EX-101.PRE 283543
65 EXTRACTED XBRL INSTANCE DOCUMENT cycc-20240331x10q_htm.xml XML 665304
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50626 | Film No.: 24945672
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)